Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | standudu |
|---|---|
| Group name | EquipeCTCS |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://academic.oup.com/annonc/article-pdf/27/9/1725/19446793/mdw260.pdf |
| Accessed | 2019/05/15 - 13:27:12 |
| Date Added | 2019/05/15 - 11:27:12 |
| Date Modified | 2019/05/15 - 11:27:12 |
| Parent item | Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de